Jane Street
ACUR

Jane Street’s Acura Pharmaceuticals ACUR Stock Holding History

Jane Street’s Portfolio ACUR Stock Details ACUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,348
Closed -$18K – 3392
2014
Q2 		$18K Sell
3,348
-1,965
-37% -$11.9K ﹤0.01% 2480
2014
Q1 		$39K Buy
+5,313
New +$46.1K ﹤0.01% 2600
2013
Q3 		– Sell
-2,400
Closed -$23K – 3386
2013
Q2 		$23K Buy
+2,400
New +$27.1K ﹤0.01% 2592

Other funds holding ACUR

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

Jane Street's ACUR Position: Q3 2014 in Review

Jane Street sold out of Acura Pharmaceuticals (ACUR) in Q3 2014, closing a stake of 3,348 shares — an estimated $18K sold.

Jane Street first reported a position in ACUR in Q2 2013 and held it in 3 quarters. The position peaked at $39K in Q1 2014. 28 funds tracked by Wall St. Rank hold ACUR as of Q3 2014.

  • Jane Street reported no remaining Acura Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
  • Jane Street sold 3,348 Acura Pharmaceuticals shares in Q3 2014, an estimated $18K.
  • Jane Street first reported a position in Acura Pharmaceuticals in Q2 2013 and held it in 3 quarters.
  • Jane Street's Acura Pharmaceuticals position peaked at $39K in Q1 2014.
  • 28 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q3 2014.

Based on Jane Street's 13F filing for Q3 2014, filed 14 Nov 2014.